TomoTherapy Enters Australian Market with Purchase by Royal Brisbane & Women’s Hospital
TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it is expanding into Australia and New Zealand. The company recently signed a distribution agreement with Nucletron Pty Ltd. and was awarded a contract by Queensland Health to supply the first TomoTherapy® treatment system in Australia to Royal Brisbane & Women’s Hospital. “Until now, we have not had the integrated technology to deliver IMRT treatments to our patients,” said a spokesperson for the Hospital. “With the installation of the TomoTherapy system, we will be able to advance our capabilities to the leading edge of IG-IMRT treatments." (9 Feb 2010) Read more




